Abstract:Abstract Background Introduction of Bare Metal Stents (BMS) was itself a revolutionary step in the history of the medical industry; however, Drug Eluting Stents (DES) maintained its superiority over BMS in every aspect from restenosis rate to late lumen loss. The reason behind the magnanimous position of the DES in the stent market is the degree of improvement with which it evolves. New and better stents come into the market every year, surpassing their predecessors by many folds. Literature review This review paper discusses the journey of DES with supporting clinical trials in detail. In the first generation, there were stainless-steel stents with thicker coatings. Although they had superior results compared to BMS, there was still room for improvement. Afterward came the second-generation stents, which had superior metal platforms with thinner struts and thin coatings. The drugs were also changed from Paclitaxel and Sirolimus to Zotrolimus and Everolimus. These stents performed best; however, there was an issue of permanent coating, which remained intact over the stent surface after complete drug elution and started to cause issues in longer-term studies. Hence, an improved version of DES was introduced to these permanent coatings called the third generation of drug eluting stents, which initially utilized biodegradable polymer and ultimately moved towards polymer free drug coatings. This generation has introduced a unique amalgam of technologies to achieve its polymer free coatings; however, researchers have numerous prospects of growth in this field. This review paper highlights the major coups of stent technology evolution from BMS to DES, from thick polymeric coatings to thin coatings and from durable polymers to polymer free DES. Conclusion In conclusion, though the medical industry promptly accepted BMS as the best treatment option for cardiovascular diseases; however, DES has provided even better results than BMS. In DES, the first and second generation has ruled the technology for many years and are still on the shelves. Still, the issues aroused due to durable polymer shifted the attention towards biodegradable drug eluting stents, the third generation growing rapidly. But the scientific community has not restricted themselves and is investigating bioresorbable stents that completely eliminate the polymer intervention in drug eluting stent technology.

S160 Dexamethasone-Eluting and Self-Expanding Biodegradable Stents Effectively Reduce Fibrosis in Cases of Biliary Stricture

A Short Fully Covered Self-Expandable Metal Stent for Management of Benign Biliary Stricture Not Caused by Living-Donor Liver Transplantation

Preventive effect of biodegradable stents on biliary stricture and fibrosis after biliary anastomosis in a porcine model

Biliary stents for active materials and surface modification: Recent advances and future perspectives

Bio-resorbable polymer stents: a review of material progress and prospects

The Progress of Biodegradable Biliary Stents

Biosynthetic Plastics as Tunable Elastic and Visible Stent with Shape‐Memory to Treat Biliary Stricture

S173 Metal Stents Prove Superior to Plastic Stents in Managing Biliary Strictures: A Systematic Review

Three-months duration of fully-covered metal stent for refractory dominant extra-hepatic biliary stricture among primary sclerosing cholangitis patients: efficacy and safety

Biodegradable JDBM coating stent has potential to be used in the treatment of benign biliary strictures

A review on biodegradable biliary stents: materials and future trends

Study of Biodegradable and Self-Expandable PLLA Helical Biliary Stent in Vivo and in Vitro

Temporary placement of covered self-expandable metal stents in benign biliary strictures: a new paradigm? (with video)

Evolutionary perspective of drug eluting stents: from thick polymer to polymer free approach

Biodegradable biliary stents placement using a "kissing‐stent" technique for management of a recalcitrant stricture post‐live donor liver transplant

S1628 Efficacy of Endoscopic Treatment of Post Living Donor Liver Transplant Biliary Strictures

Drug-Eluting Biodegradable Poly-D/L-Lactic Acid Vascular Stents: An Experimental Pilot Study

An overview of polymer-based-bioresorbable drug-eluting stents

Towards a Customizable, SLA 3D-Printed Biliary Stent: Optimizing a Commercially Available Resin and Predicting Stent Behavior with Accurate In Silico Testing

3D-printed, citrate-based bioresorbable vascular scaffolds for coronary artery angioplasty

Biofunctional coatings and drug-coated stents for restenosis therapy